[HTML][HTML] Macrocycle-antibiotic hybrids: A path to clinical candidates

AS Surur, D Sun - Frontiers in Chemistry, 2021 - frontiersin.org
The tale of abate in antibiotics continued defense mechanisms that chaperone the rise of
drug-defying superbugs—on the other hand, the astray in antibacterial drug discovery and …

Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates

AS Surur, D Sun - Design of Macrocyclic Compounds for …, 2021 - books.google.com
The tale of abate in antibiotics continued defense mechanisms that chaperone the rise of
drug-defying superbugs—on the other hand, the astray in antibacterial drug discovery and …

[HTML][HTML] Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates

AS Surur, D Sun - Frontiers in Chemistry, 2021 - ncbi.nlm.nih.gov
The tale of abate in antibiotics continued defense mechanisms that chaperone the rise of
drug-defying superbugs—on the other hand, the astray in antibacterial drug discovery and …

Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates

AS Surur, D Sun - Frontiers in chemistry, 2021 - pubmed.ncbi.nlm.nih.gov
The tale of abate in antibiotics continued defense mechanisms that chaperone the rise of
drug-defying superbugs-on the other hand, the astray in antibacterial drug discovery and …

Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates.

AS Surur, D Sun - Frontiers in Chemistry, 2021 - europepmc.org
The tale of abate in antibiotics continued defense mechanisms that chaperone the rise of
drug-defying superbugs—on the other hand, the astray in antibacterial drug discovery and …

Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates

AS Surur, D Sun - Frontiers in Chemistry, 2021 - ui.adsabs.harvard.edu
The tale of abate in antibiotics continued defense mechanisms that chaperone the rise of
drug defying superbugs, on the other hand, the astray in antibacterial drug discovery and …